Literature DB >> 31626982

Efficacy and safety of Ergoferon versus oseltamivir: Reply to the Letter to the Editor.

Elena Andrianova1, Mikhail Putilovskiy2.   

Abstract

Entities:  

Year:  2019        PMID： 31626982     DOI： 10.1016/j.ijid.2019.09.028

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN： 1201-9712            Impact factor:   3.623


× No keyword cloud information.
  3 in total

1.  Efficacy and Safety of Ergoferon in Children from 6 Months to 6 Years Old with Acute Respiratory Viral Infections in Contemporary Outpatient Practice: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial.

Authors:  N A Geppe; B M Blokhin; O V Shamsheva; S T Abdrakhmanova; K A Alikhanova; G T Myrzabekova
Journal:  Can Respir J       Date:  2021-11-15       Impact factor: 2.409

2.  The randomized clinical trial results of the anxiety treatment in patients with somatoform dysfunction and neurotic disorders.

Authors:  Vladimir Anatolevich Parfenov; Pavel Rudolfovich Kamchatnov; Dina Rustemovna Khasanova; Enver Ibragimovich Bogdanov; Tatiana Markovna Lokshtanova; Aleksandr Vitalevich Amelin; Natalya Nikolaevna Maslova; Nataliia Vyacheslavovna Pizova; Galina Nikolaevna Belskaya; Evgeny Robertovich Barantsevich; Gulsum Abdurahmanovna Duchshanova; Saltanat Ualihanovna Kamenova; Oleg Vladimirovich Kolokolov; Alexey Borisovich Glazunov
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.996

Review 3.  The Clinical and Biological Effects of Homeopathically Prepared Signaling Molecules: A Scoping Review.

Authors:  Raj Kumar Manchanda; Meeta Gupta; Ankit Gupta; Robbert van Haselen
Journal:  Homeopathy       Date:  2021-11-19       Impact factor: 1.444
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.